Locations:
Search
Both Approaches Deemed Safe and Effective in Research by Cleveland Clinic and Cardiothoracic Surgical Trials Network
Glycemic control, weight loss endure out to five years
Clinical Trial Stopped Early After Preliminary Data Indicated Drug Was Not Effective
Research Also Shows that Evolocumab Is Superior to Ezetimibe for Lowering Cholesterol in Statin-Intolerant Patients
Research Finds TMAO – A Gut Byproduct of Animal-Rich Diets – Encourages Over-Reactive Platelet Function, Increasing Thrombosis Risk
Patient in Stable Condition; Additional Information to be Available at Press Conference Next Week
